Abstract
BackgroundHepatitis A virus (HAV) can cause significant pathology in patients with chronic hepatitis B virus (HBV), however, HAV can be prevented by vaccination. The aim of this study was to determine the implication of vaccination against HAV vaccine in patients with chronic hepatitis B.Materials and methodsThe seroprevalence of anti-HAV IgG antibodies was investigated in the patients with chronic hepatitis B. Anti-HAV IgG antibodies were detected by commercially available ELISA kit.ResultsA total of 673 patients (354 males, 319 females with age range of 17-78 years) with chronic hepatitis B were included the study. Hepatitis A virus seropositivity rate was 34% in the patients younger than 20 years, 79% in the age group of 20 to 29 years, and 100% after 35 years of age.DiscussionHepatitis A virus vaccination may be recommended for young adult patients with chronic hepatitis B in Turkey.How to cite this articleTulek N, Ozsoy M, Moroglu C, Sonmezer MC, Temocin F, Ertem GT, Erdinc FS. Seroprevalence of Hepatitis A Virus Antibodies among the Patients with Chronic Hepatitis B in Turkey. Euroasian J Hepato-Gastroenterol 2015;5(2):95-97.
Highlights
Hepatitis A is an acute contagious diseases caused by a single stranded RNA virus belong to Picarnoviridae family
Hepatitis A virus vaccination may be recommended for young adult patients with chronic hepatitis B in Turkey
Seroprevalence of Hepatitis A Virus Antibodies among the Patients with Chronic Hepatitis B in Turkey
Summary
Hepatitis A is an acute contagious diseases caused by a single stranded RNA virus belong to Picarnoviridae family. While most of infections are asymptomatic in childhood, it is symptomatic in three quarters of adults and causes to icteric acute hepatitis. It is generally benign diseases, prognosis is generally good and it leaves longterm immunity. Mortality rate increases with age and mortality is higher among the patients with chronic liver diseases.[1] hepatitis A vaccination is recommended as a part of management of chronic hepatitis B, more insights are required in this context. Hepatitis A virus (HAV) can cause significant pathology in patients with chronic hepatitis B virus (HBV), HAV can be prevented by vaccination. The aim of this study was to determine the implication of vaccination against HAV vaccine in patients with chronic hepatitis B
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
